Stephen Dale

552 total citations
6 papers, 352 citations indexed

About

Stephen Dale is a scholar working on Pharmacology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Stephen Dale has authored 6 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Pathology and Forensic Medicine and 2 papers in Dermatology. Recurrent topics in Stephen Dale's work include Lymphoma Diagnosis and Treatment (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and Inflammatory mediators and NSAID effects (1 paper). Stephen Dale is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and Inflammatory mediators and NSAID effects (1 paper). Stephen Dale collaborates with scholars based in United Kingdom, United States and Italy. Stephen Dale's co-authors include Klaus Fenchel, Wolfram C. M. Dempke, Peter Uciechowski, Dipak Kanabar, Mark Lansdown, Robert E. Coleman, Douglas E. Merkel, W. Bolten, Nicolaì Maass and Peyman Hadji and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Stephen Dale

5 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Dale United Kingdom	5	203	113	68	54	54	6	352
Qiang Yan China	10	131 0.6×	147 1.3×	15 0.2×	76 1.4×	44 0.8×	28	385
S Costantini Italy	9	121 0.6×	73 0.6×	43 0.6×	49 0.9×	59 1.1×	19	379
Bingying Xie China	13	89 0.4×	61 0.5×	47 0.7×	124 2.3×	44 0.8×	17	459
Ingolf Juhasz-Böess Germany	12	96 0.5×	23 0.2×	74 1.1×	87 1.6×	27 0.5×	28	397
Meng Jin China	11	98 0.5×	41 0.4×	55 0.8×	73 1.4×	37 0.7×	28	381
Masayuki Endo Japan	9	46 0.2×	47 0.4×	45 0.7×	109 2.0×	31 0.6×	20	323
Tenglong Tang China	10	302 1.5×	50 0.4×	23 0.3×	75 1.4×	65 1.2×	20	474
Bo Ma China	6	78 0.4×	40 0.4×	26 0.4×	95 1.8×	67 1.2×	16	326
Mamta Joshi United Kingdom	8	165 0.8×	40 0.4×	41 0.6×	32 0.6×	21 0.4×	16	371

Countries citing papers authored by Stephen Dale

Since Specialization

Citations

This map shows the geographic impact of Stephen Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Dale more than expected).

Fields of papers citing papers by Stephen Dale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Dale. The network helps show where Stephen Dale may publish in the future.

Co-authorship network of co-authors of Stephen Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Dale. A scholar is included among the top collaborators of Stephen Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Dale. Stephen Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hanna, George J., Douglas R. Adkins, Rohit Mehra, et al.. (2025). 1349P Tipifarnib (TIP) and alpelisib (ALP) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase I results from KURRENT-HN. Annals of Oncology. 36. S783–S784.

2.

Porcu, Pierluigi, Stacie Hudgens, Sarah McCue Horwitz, et al.. (2020). Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(2). 97–105. 20 indexed citations

3.

Porcu, Pierluigi, Stacie Hudgens, Pietro Quaglino, et al.. (2018). Quality of life in cutaneous T-cell lymphoma subjects treated with anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from the phase 3 MAVORIC trial.. Journal of Clinical Oncology. 36(15_suppl). 7577–7577. 4 indexed citations

4.

Dempke, Wolfram C. M., Klaus Fenchel, Peter Uciechowski, & Stephen Dale. (2017). Second- and third-generation drugs for immuno-oncology treatment—The more the better?. European Journal of Cancer. 74. 55–72. 184 indexed citations

5.

Kanabar, Dipak, et al.. (2007). A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clinical Therapeutics. 29(12). 2716–2723. 42 indexed citations

6.

Coleman, Robert E., W. Bolten, Mark Lansdown, et al.. (2007). Aromatase inhibitor-induced arthralgia: Clinical experience and treatment recommendations. Cancer Treatment Reviews. 34(3). 275–282. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact